Keywords: sankyo, hits, forecasts, spending, delayed, japan, reported
Sankyo hits forecasts, R&D spending delayed
Article | 24 November 2003
Japan's Sankyo has reported results in line with its upward revision ofOctober 31. Operating income rose 10.2% to 51.0 billion yen ($468.2 million), exceeding ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
